BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18256232)

  • 1. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.
    Shann YJ; Cheng C; Chiao CH; Chen DT; Li PH; Hsu MT
    Genome Res; 2008 May; 18(5):791-801. PubMed ID: 18256232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.
    Yegnasubramanian S; Wu Z; Haffner MC; Esopi D; Aryee MJ; Badrinath R; He TL; Morgan JD; Carvalho B; Zheng Q; De Marzo AM; Irizarry RA; Nelson WG
    BMC Genomics; 2011 Jun; 12():313. PubMed ID: 21669002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.
    Yamamoto M; Cid E; Bru S; Yamamoto F
    PLoS One; 2011 Mar; 6(3):e17149. PubMed ID: 21423795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-methylated Genomic Sites Coincidence Cloning (NGSCC): an approach to large scale analysis of hypomethylated CpG patterns at predetermined genomic loci.
    Azhikina T; Gainetdinov I; Skvortsova Y; Batrak A; Dmitrieva N; Sverdlov E
    Mol Genet Genomics; 2004 Feb; 271(1):22-32. PubMed ID: 14666421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
    Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
    Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
    Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
    J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2.
    Aporntewan C; Phokaew C; Piriyapongsa J; Ngamphiw C; Ittiwut C; Tongsima S; Mutirangura A
    PLoS One; 2011 Mar; 6(3):e17934. PubMed ID: 21423624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common altered epigenomic domains in cancer cells: characterization and subtle variations.
    Tsai YC; Chiao CH; Chang IY; Chen DT; Liu TT; Hua K; Chang CH; Hsu MT
    Cancers (Basel); 2011 Apr; 3(2):1996-2013. PubMed ID: 24212793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation.
    Borghese B; Barbaux S; Mondon F; Santulli P; Pierre G; Vinci G; Chapron C; Vaiman D
    Mol Endocrinol; 2010 Sep; 24(9):1872-85. PubMed ID: 20685852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of unmethylated sites in rDNA repeats in barley NOR deletion line.
    Dimitrova AD; Georgiev O; Mishev K; Tzvetkov S; Ananiev ED; Karagyozov L
    J Plant Physiol; 2016 Oct; 205():97-104. PubMed ID: 27649325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide profiling of promoter methylation in human.
    Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
    Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome.
    Hampton OA; Den Hollander P; Miller CA; Delgado DA; Li J; Coarfa C; Harris RA; Richards S; Scherer SE; Muzny DM; Gibbs RA; Lee AV; Milosavljevic A
    Genome Res; 2009 Feb; 19(2):167-77. PubMed ID: 19056696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line.
    Matzner I; Savelyeva L; Schwab M
    Cancer Lett; 2003 Jan; 189(2):207-19. PubMed ID: 12490314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.
    Chen CM; Chen HL; Hsiau TH; Hsiau AH; Shi H; Brock GJ; Wei SH; Caldwell CW; Yan PS; Huang TH
    Am J Pathol; 2003 Jul; 163(1):37-45. PubMed ID: 12819009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
    Tryndyak V; Kovalchuk O; Pogribny IP
    Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome.
    Simo-Riudalbas L; Diaz-Lagares A; Gatto S; Gagliardi M; Crujeiras AB; Matarazzo MR; Esteller M; Sandoval J
    PLoS One; 2015; 10(7):e0132517. PubMed ID: 26161907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.
    Selzer RR; Richmond TA; Pofahl NJ; Green RD; Eis PS; Nair P; Brothman AR; Stallings RL
    Genes Chromosomes Cancer; 2005 Nov; 44(3):305-19. PubMed ID: 16075461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.